Logo

real-time PCR

UK Startup LEX Diagnostics Developing Ultra-Fast Low-Cost PCR for Infectious Disease Dx
Premium

At the AMP annual meeting this week, the company outlined its technology and vision for a speedy, low-cost, high-accuracy diagnostic.

Alercell to Distribute Amoy Diagnostic Ros1 Gene Fusion Detection Kit in US

The 14-fusion PCR assay for lung cancer subtyping is available for research-use only but will be more broadly distributed when the kits gain FDA clearance.

Qiagen Gets CE Mark for High-Capacity Syndromic Testing Platform

The company also launched updated versions of its CE-marked respiratory and gastrointestinal testing panels for use on the QiaStat-Dx systems.

Genetic Signatures Wins Contract From Public Health Wales for Enteric Pathogen Testing

Under the three-year contract, worth up to A$1.8 million (US$1.4 million) per year, the Australian firm will provide testing to seven sites within Wales.

Qiagen Looks to Convert Pandemic Sales Surge Into Long-Term Growth
Premium

COVID-19 accelerated the growth of several product portfolios, but under CEO Thierry Bernard, the company is ready to put the pandemic behind it — mostly.

Nov 5, 2021

Qiagen Settles Becton Dickinson Patent Infringement Lawsuit for $53M

Apr 8, 2021

Armed With $55M in New Funding, Nucleix to Further Invest in Early-Stage Lung Cancer Dx
Premium

Mar 8, 2021

With Diagenode Acquisition, Hologic Expects to Expand Panther Fusion Testing Menu
Premium

Feb 11, 2021

Bio-Rad Q4 Revenues Jump 27 Percent; Firm Gets FDA EUA for COVID/Flu Combo Test

Dec 15, 2020

Anitoa Systems Gets CE-IVD Mark for Portable qPCR Instrument

Dec 10, 2020

Following Acquisition, UK Firm MyHealthChecked Launches SARS-CoV-2 Consumer Testing Service
Premium

Dec 3, 2020

DnaNudge Deploys Direct-to-Consumer Service for PCR-Based Pool Testing of SARS-CoV-2
Premium

Nov 12, 2020

PerkinElmer Coronavirus RT-PCR Assay Receives CE Mark for Saliva Use, Sample Pooling

Oct 29, 2020

Biocartis, Exact Sciences Terminate Oncotype DX Agreement

Oct 27, 2020

Qiagen Reports 26 Percent Q3 Revenue Growth; Ups Full-Year Guidance

Oct 16, 2020

Interdisciplinary NIST Team Claims qPCR Improvements Using Unusual Math Tweaks
Premium

Sep 25, 2020

Genetron, CStone Launch Clinical Trial to Develop CDx for Cancer Drug Avapritinib

Sep 1, 2020

Immunexpress, Biocartis to Roll Out Sepsis Test in Europe Ahead of Planned US Launch
Premium

Aug 5, 2020

Roche Epstein-Barr Virus Quantitative Test Receives FDA Clearance

Jul 31, 2020

NIH Awards $249M to Seven Firms for Rapid Acceleration of COVID-19 Diagnostics

Jun 19, 2020

Improved Pool Testing Methods Could Enable COVID-19 Screening as Pandemic Continues
Premium

May 27, 2020

BioGX, Bosch Healthcare Solutions Partner to Develop Point-of-Care Infectious Disease Tests

May 19, 2020

Israel's Nucleix Targeting US Market With Noninvasive Bladder, Lung Cancer Assays
Premium

May 18, 2020

Ubiquitome, DKSH Sign Asia Pacific Distribution Agreement for Mobile COVID-19 Testing Platform

May 15, 2020

Case Study Shows Power of SARS-CoV-2 Genome Testing to Track Viral Spread, ID Strains
Premium

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.